胺诱导的多巴胺释放预测了第一期精神病的1年结果:自然主义的观察
Ana Weidenauer1,2,3,4, Ulrich Sauerzopf5,6, Martin Bauer5,6,7,8
1Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Vienna, Austria.
Schizophrenia bulletin
|August 13, 2024
概括
在特定的大脑区域释放多巴胺,通过d-安非他胺挑战测量,与第一个情节精神分裂症的症状严重程度相关. 这一发现可能有助于预测精神分裂症患者的治疗反应.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 放射学 放射学是一门学科.
背景情况:
- 精神分裂症的多巴胺理论认为,通过抗精神病药物阻断多巴胺D2/3受体可以缓解症状.
- 相当一部分精神分裂症患者对当前的抗精神病治疗没有充分的反应.
- 识别治疗反应的预测因素对于优化第一发精神分裂症治疗至关重要.
研究的目的:
- 为了研究d-安非他胺诱导的多巴胺释放作为一种潜在的预测1年的临床结果在抗精神病药物原始患者的第一发精神分裂症.
- 探索多巴胺系统功能与症状严重程度和持续性之间的关系.
主要方法:
- 21名未曾服用过抗精神病药物的患者接受了[11C]-(+) -PHNO正子发射断层扫描.
- 通过比较扫描与没有d-安非他胺预治疗的情况来估计多巴胺释放.
- 用积极和消极综合征量表 (PANSS) 在1年内评估临床结果.
主要成果:
- 室内条纹体中多巴胺释放与积极症状的减少有关.
- 球体中多巴胺释放与PANSS负,一般和总症状得分的下降相关.
- 在黑质体/腹膜膜区域释放多巴胺的增加预测了一般症状的减少,而膜结合与负面症状严重程度相关.
结论:
- 探索性结果表明,d-胺诱导的多巴胺释放与精神病的第一年症状严重程度和持续性之间存在联系.
- 这些发现可能会为精神分裂症的个性化治疗策略提供见解.
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
208
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
208
01:26Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
529
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
529
01:15Drug Abuse and Addiction: Pharmacological Phenomena
455
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
455
01:21Antipsychotic Drugs: Typical and Atypical Agents
164
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
164
01:29Biological Causes of Schizophrenia
51
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
51